Marlise R Luskin Selected Research

nelarabine (506U78)

1/2016

Nelarabine, cyclosphosphamide and etoposide for adults with relapsed T-cell acute lymphoblastic leukaemia and lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marlise R Luskin Research Topics

Disease

11	Neoplasms (Cancer) 04/2022 - 09/2015
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 03/2016
6	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 07/2015
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 08/2017
3	Viremia 04/2008 - 12/2006
2	Osteonecrosis (Kienbock's Disease) 11/2022 - 01/2022
2	Leukemia 01/2022 - 12/2015
2	Lymphoma (Lymphomas) 01/2016 - 04/2014
1	Hemorrhage 10/2022
1	Disseminated Intravascular Coagulation 10/2022
1	Vision Disorders (Hemeralopia) 10/2022
1	Philadelphia Chromosome 04/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022
1	Eosinophilia 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Essential Thrombocythemia 01/2022
1	Polycythemia Vera 01/2022
1	Carcinogenesis 01/2022
1	Mycoses (Diseases, Fungus) 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2020
1	Aneuploidy (Aneuploid) 08/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 08/2017
1	Genomic Instability 01/2017
1	Second Primary Neoplasms (Neoplasms, Second) 09/2015
1	Lung Diseases (Lung Disease) 09/2015
1	Infertility (Sterility) 09/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2015
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2015
1	Infections 04/2008
1	Human Influenza (Influenza) 03/2007
1	Immune Reconstitution Inflammatory Syndrome 12/2006

Drug/Important Bio-Agent (IBA)

2	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2019
2	Interferon Type IIBA 04/2008 - 12/2006
2	CytokinesIBA 03/2007 - 12/2006
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022
1	Asparaginase (Elspar)FDA Link 11/2022
1	Retinaldehyde (Retinal)IBA 10/2022
1	Dacarbazine (DIC)FDA LinkGeneric 10/2022
1	Tyrosine Kinase InhibitorsIBA 04/2022
1	GlucocorticoidsIBA 01/2022
1	ChromatinIBA 01/2022
1	Core Binding Factors (Core-Binding Factor)IBA 01/2022
1	Inotuzumab OzogamicinIBA 01/2022
1	Imatinib Mesylate (Gleevec)FDA Link 01/2022
1	venetoclaxIBA 01/2022
1	Polycomb Repressive Complex 2IBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	gilteritinibIBA 01/2021
1	TriazolesIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 08/2019
1	Biological ProductsIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	midostaurinIBA 12/2017
1	Cell-Free Nucleic AcidsIBA 08/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	CytosineIBA 01/2017
1	Daunorubicin (Cerubidine)FDA LinkGeneric 03/2016
1	nelarabine (506U78)FDA Link 01/2016
1	Etoposide (VP 16)FDA LinkGeneric 01/2016
1	Ribavirin (Virazole)FDA LinkGeneric 04/2008
1	Interferon-alpha2bIBA 04/2008
1	Interferon-alpha (Interferon Alfa)IBA 04/2008
1	Interferon-gamma (Interferon, gamma)IBA 03/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2007
1	HIV AntigensIBA 03/2007
1	Interleukin-2 (IL2)IBA 03/2007
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 03/2007
1	LipopolysaccharidesIBA 12/2006

Therapy/Procedure

9	Therapeutics 01/2022 - 12/2006
4	Drug Therapy (Chemotherapy) 04/2022 - 09/2015
4	Hematopoietic Stem Cell Transplantation 11/2016 - 07/2015
3	Cell Transplantation 01/2021 - 01/2017
2	Aftercare (After-Treatment) 04/2022 - 01/2021
2	Transplantation 01/2022 - 11/2016
2	Stem Cell Transplantation 11/2016 - 02/2015
1	Induction Chemotherapy 10/2022
1	Music Therapy 04/2022